They develop safe-by-design, more stable and efficient, adjuvant- and needle-free vaccines. Our patented technology centers on the use of bioavailable and bioeliminable nanoparticles.
Vaxinano is an R&D biotech aiming to bring potential vaccines to market in partnership with the pharmaceutical sector. They develop proofs-of-concept for new vaccines and can improve existing ones. Our experimental vaccines target toxoplasmosis and tuberculosis, and they are developing anti-bacterial, anti-viral and anti-parasitic vaccines.
In addition to vaccine development, they perform contract research and assist our customers in their nanomedicine R&D. Vaxinano can work with you towards a solution for your vaccine projects, and they welcome the challenge of meeting your needs.
